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Abstract
Background: Peroxisome proliferator activated receptor-alpha (PPARα) is a ubiquitously expressed nuclear receptor.
The role of endogenous PPARα in retinal neuronal homeostasis is unknown. Retinal photoreceptors are the highest
energy-consuming cells in the body, requiring abundant energy substrates. PPARα is a known regulator of lipid
metabolism, and we hypothesized that it may regulate lipid use for oxidative phosphorylation in energetically
demanding retinal neurons.
Results: We found that endogenous PPARα is essential for the maintenance and survival of retinal neurons, with
Pparα-/- mice developing retinal degeneration first detected at 8 weeks of age. Using extracellular flux analysis, we
identified that PPARα mediates retinal utilization of lipids as an energy substrate, and that ablation of PPARα
ultimately results in retinal bioenergetic deficiency and neurodegeneration. This may be due to PPARα regulation of
lipid transporters, which facilitate the internalization of fatty acids into cell membranes and mitochondria for
oxidation and ATP production.
Conclusion: We identify an endogenous role for PPARα in retinal neuronal survival and lipid metabolism, and
furthermore underscore the importance of fatty acid oxidation in photoreceptor survival. We also suggest PPARα as a
putative therapeutic target for age-related macular degeneration, which may be due in part to decreased
mitochondrial efficiency and subsequent energetic deficits.
Keywords: Age-related macular degeneration, Retina, Neurodegeneration, Retinal energy metabolism, Mitochondria,
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Background
In order to transduce light signals, photoreceptors must
maintain a steep membrane gradient that constantly fluctu-
ates in response to light stimuli, which is energetically
demanding [1]. Photoreceptor mitochondria therefore
function at full capacity with a limited respiratory reserve,
and require abundant energy substrates and oxygen [2].
Fuel shortages or impairment of mitochondrial function are
therefore detrimental to photoreceptor survival, and quickly
result in neurodegeneration. Accordingly, mitochondrial
dysfunction has been linked to a litany of retinal diseases,
including age-related macular degeneration, diabetic retin-
opathy, macular telangtasia and, potentially, retinal degen-
erations [3]. Further, a growing body of evidence suggests
that neurodegenerative diseases of the brain and peripheral
nervous system may also have a metabolic root [4, 5]. It is
therefore imperative to further the understanding of neur-
onal energy metabolism such that additional therapeutics
targeting metabolic dysregulation can be developed.
Age-related macular degeneration (AMD) is characterized
by degeneration of the neural retina and retinal pigment
epithelium with subsequent compensatory but ultimately
pathological neovascularization in advanced stages. This
response may be due in part to mitochondrial dysfunction
with aging and subsequent decreased ATP production in
photoreceptors [3, 6]. Previous dogma suggested that retinal
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neurons rely exclusively on glucose as a fuel source [1], but
a recent study identified that retinal neurons use both
glucose and lipids for ATP production [7]. However, because
lipid use in retinal neurons is newly identified, the mediators
of retinal fatty acid oxidation (FAO) are currently unknown.
Here we identify a central role for peroxisome proliferator
activated receptor-alpha (PPARα) in retinal FAO, and
furthermore demonstrate that FAO is crucial for the main-
tenance and survival of retinal neurons in physiological
conditions.
Although PPARα activation has therapeutic effects in neu-
rodegenerative conditions [8], its endogenous role in neuronal
homeostasis and survival is incompletely understood. PPARα
is a regulator of FAO, activating transcription of mitochon-
drial and cell membrane lipid transporters as well as FAO en-
zymes [9]. We find that Pparα-/- retinas have impaired use of
lipids as an oxidizable substrate for ATP production, which
may be due to changes in the transcriptional regulation of
mitochondrial lipid transporters important for FAO and/or
mitochondrial FAO enzymes. To compensate for decreased
lipid use, Pparα-/- retinas use more glycolytic products for
oxidative phosphorylation, but ultimately develop bioenergetic
insufficiency and subsequent neurodegeneration.
Lipids and glucose are both important retinal energy sub-
strates. Lipid oxidation in peroxisomes and mitochondria
occurs through FAO, yielding acetyl-CoA for the citric acid
cycle and reducing equivalents for the electron transport
chain. Glucose is catabolized to pyruvate through glycolysis,
which is then converted to lactate, or to acetyl-CoA for the
citric acid cycle. Recent studies have suggested that lipids
are used for oxidative phosphorylation by retinal neurons,
while most glucose is converted to lactate through aerobic
glycolysis [7]. However, the regulation of FAO and preferen-
tial, context-dependent use of each substrate remain
incompletely understood. Our findings also suggest that
lipids are used for oxidative phosphorylation in normal con-
ditions and that pyruvate may be more readily used as an
oxidizable substrate under the stress of impaired FAO, such
as in Pparα-/- retinas. These findings further underscore the
importance of lipids as oxidizable substrates for ATP pro-
duction in retinal neurons, and contribute to the basic un-
derstanding of retinal energy metabolism.
Together, these findings identify a central role for
PPARα in lipid metabolism and retinal neuronal survival,
and further delineate retinal metabolic flux. They also
suggest PPARα as a new therapeutic target for neurode-
generative diseases of metabolic origin, including AMD,
a leading cause of blindness in the elderly [10], and
potentially in retinal degenerations [11].
Results
Essential role of endogenous PPARα in neuronal survival
Serial electroretinogram (ERG) recordings demonstrated
that retinal function declined in Pparα-/- mice relative to
wild-type (WT) C57Bl6/J mice (Fig. 1a). The rod A-wave
declined first and was the most significantly decreased,
suggesting that rod photoreceptors were the most
significantly affected cell type. The murine retina is rod-
dominant [12] and PPARα is highly expressed in photo-
receptors [7], so these findings were consistent with
prior observations. Total retinal thickness declined pro-
gressively with age in Pparα-/- mice as demonstrated by
optical coherence tomography (OCT) (Fig. 1b). Consist-
ent with prior observations, ERG response declined in
C57Bl6/J WT mice with age, while total retinal thickness
remained unchanged (Fig. 1a, b), suggesting that the
ERG decline in WT mice was unrelated to retinal degen-
eration, but rather might have been due to increased re-
sistance of retinal neurons to electrical stimulus in WT
mice, as suggested previously [13]. Total retinal apop-
tosis was unchanged at 4 weeks of age in Pparα-/- ani-
mals, but increased at 8, 18, and 40 weeks of age
(Fig. 1c), which in combination with a progressive de-
cline in retinal function and retinal thickness suggested
persistent neurodegeneration in the absence of PPARα.
We injected PPARα-expressing adenovirus intravitreally
in 4-week-old Pparα-/- animals to selectively restore ex-
pression of PPARα in retinal neurons, and found that at
8 weeks of age, retinal apoptosis was significantly de-
creased in Pparα-/- animals injected with PPARα-
expressing adenovirus relative to those injected with GFP-
expressing adenovirus (Additional file 1: Figure S1F). This
suggested that loss of PPARα in retinal neurons was op-
erative in the observed neurodegenerative phenotype.
Glial fibrillary acidic protein (GFAP) levels were increased
in Pparα-/- retinas, suggesting retinal gliosis (Fig. 1d). Con-
sistent with prior findings, we observed a 45 kDa isoform
of GFAP after 15 weeks of age [14], which was also ele-
vated in Pparα-/- retinas (Additional file 2: Figure S2D). In
very low density lipoprotein receptor knockout (Vldlr-/-)
mice, a neurodegenerative neovascular model with some
characteristics of neovascular AMD, including photo-
receptor energy insufficiency [7, 15], treatment with
PPARα agonist fenofibric acid decreased total retinal
apoptosis (Fig. 1e). Taken together, these findings suggest
that endogenous PPARα is essential for retinal neuronal
survival under normal conditions, and that PPARα activa-
tion protects against retinal degeneration in an AMD-like
model with photoreceptor energy deficits.
Decreased vascular density in Pparα-/- retinas
Energetically demanding photoreceptors dictate vascular
outgrowth to ensure that metabolic needs are met [7].
At 40 weeks of age, vascular density in the superficial
and deep vascular plexuses was decreased in Pparα-/-
retinas, as demonstrated by decreased total vascular
length (Fig. 2c), decreased number of vascular junctions
(Fig. 2d), and decreased number of vascular meshes in
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the deep vascular plexus (Fig. 2e). We suggest that the
decreased number and metabolic activity of retinal neu-
rons may dictate the survival of retinal blood vessels in
Pparα-/- retinas. Neurodegeneration is first detectable by
8 weeks of age in Pparα-/- retinas (Fig. 1c). Consistent
with retinal neurons controlling vascular survival, vascu-
lar density was modestly decreased in 8-week-old
Pparα-/- retinas, particularly in the central retina, which
is the highest energy-consuming region of the retina
(Additional file 3: Figure S3). Importantly, we have pre-
viously demonstrated that hypoxic signaling is not acti-
vated in Pparα-/- retinas under normal conditions [16],
suggesting that the relatively subtle decreases of vascular
density are not sufficient to induce neuronal ischemia.
Other hallmarks of vascular dysfunction, such as vascu-
lar hyperpermeability, formation of acellular capillaries,
and leukostasis, are also unchanged in Pparα-/- retinas
under normal conditions [17]. We have also previously
identified that PPARα is most highly expressed in photo-
receptors [7]. Together, these findings suggest that the
relatively subtle decreases in vascular density are un-
likely to be operative in the robust neurodegenerative
phenotype, but are rather likely secondary to decreased
neuronal energetic demand due to decreased metabolic
rates and loss of retinal neurons.
Role of PPARα in retinal lipid metabolism
These findings prompted us to explore the role of
PPARα in retinal energy metabolism. Therefore, we first
examined FAO in WT and Pparα-/- retinas. To ensure
that any changes in substrate use were not secondary to
neurodegeneration, we used 4-week-old animals, prior
to the onset of neurodegeneration in Pparα-/- retinas
(Fig. 1c). In WT retinas, fatty acid palmitate increased
oxygen consumption rate (OCR) (Fig. 3a, b), which was
reversed by the carnitine palmitoyltransferase 1A (Cpt1a)
Fig. 1 Essential role of PPARα in retinal neuronal survival. a Longitudinal electroretinography revealed that retinal function (rod and cone A-waves and
B-waves) declined in Pparα-/- mice relative to wild-type (WT) starting at 7 weeks (7, 9, 11, and 26 weeks, n = 5 mice/genotype; 52 weeks, n = 8 mice/
genotype). b Cross-sectional optical coherence tomography demonstrated that total retinal thickness progressively declined in Pparα-/- mice and
remained constant in WT (13 weeks, n = 9 mice/genotype; 26 weeks, WT n = 9, Pparα-/- n = 8; 60 weeks, n = 8 mice/genotype). c Retinal cell death ELISA
identified that total retinal apoptosis was significantly increased in Pparα-/- retinas relative to WT beginning at 8 weeks of age (n = 5 retinas/genotype per time
point). d Retinal GFAP levels were increased in Pparα-/- retinas relative to WT, suggesting retinal gliosis (8, 15 weeks, n = 5 retinas/genotype; 40 weeks, n = 6
retinas/genotype). e Retinal cell death ELISA revealed that total retinal apoptosis was significantly increased in Vdllr-/- mice and restored to baseline by
treatment with PPARα agonist fenofibric acid (Feno) (WT Veh, n = 7; WT Feno, n = 8; Vdllr-/- Veh, n = 7; Vdllr-/- Feno, n = 8). Data are expressed as mean± SEM.
*P≤ 0.05; **P≤ 0.01; ***P≤ 0.001; ****P≤ 0.0001, unpaired two-tailed Student’s t test (a–d) or one-way ANOVA with Tukey’s post-hoc comparison (e)
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inhibitor etomoxir (Additional file 4: Figure S4A, B), sug-
gesting that lipid is used for oxidative phosphorylation by
WT retinas. In contrast, palmitate did not increase OCR in
Pparα-/- retinas (Fig. 3c, d), which was not affected by
etomoxir (Additional file 4: Figure S4C, D), suggesting that
lipid is not used for oxidative phosphorylation in the
absence of PPARα. Further, oral administration of the
PPARα agonist fenofibrate for 4 weeks prior to tissue
harvest increased oxygen consumption in isolated rat retinal
mitochondria provided with lipid palmitoylcarnitine as an
oxidizable substrate, suggesting that PPARα activation
increased FAO (Fig. 3e, f ). PPARα regulates FAO by acti-
vating transcription of lipid transporter and FAO target
genes [9]. We measured RNA levels of a panel of lipid
transporters and FAO enzymes in 4-week-old WT and
Pparα-/- retinas, and found reductions in lipid transporter
Cpt1A, which is considered the rate limiting enzyme for
FAO, fatty acid binding protein 3 (Fabp3), and solute car-
rier 25a20 (Slc25a20) (Fig. 3g). RNA levels of most FAO
enzymes were unaffected by PPARα ablation (Additional
file 4: Figure S4E), with the exception of acetyl-CoA acyl-
transferase 2 (Acaa2) and medium-chain acetyl-CoA de-
hydrogenase (Acadm), which were decreased in Pparα-/-
retinas (Fig. 3g). Taken together, these findings suggest
that PPARα is essential for retinal utilization of lipids for
ATP production, which is regulated by transcription of
lipid-metabolizing PPARα target genes, including lipid
transporters and FAO enzymes.
Compensatory use of glycolytic products for oxidative
phosphorylation in Pparα-/- retinas
To further explore PPARα’s role in retinal energy metabol-
ism, we examined whether PPARα loss affected the use of
glycolytic products for oxidative metabolism. Prior findings
demonstrated that in normal conditions, the majority of
glucose is converted to lactate through aerobic glycolysis in
the retina [7]. We hypothesized that Pparα-/- retinas may
compensate for impaired FAO by using more glycolytic
products for oxidative phosphorylation, and thus measured
oxygen consumption in response to pyruvate, the primary
glycolytic product used to generate acetyl-CoA for aerobic
respiration. In WT retinas, increasing pyruvate (5 mM vs.
0.5 mM) did not affect maximal OCR (Fig. 4a, b), support-
ing the notion that pyruvate is not readily used for oxidative
phosphorylation in WT retinas [7]. In contrast, pyruvate
significantly increased maximal OCR in Pparα-/- retinas
(Fig. 4b, c), suggesting that glycolytic products are more
readily used for oxidative phosphorylation in the absence of
PPARα. Oral administration of the PPARα agonist fenofi-
brate in WT animals prior to tissue harvest did not affect
OCR in isolated retinal mitochondria provided with pyru-
vate as an oxidizable substrate (Fig. 4e, Additional file 5:
Fig. 2 Decreased vascular density in Pparα-/- retinas. a Representative images of isolectin-labeled microvessels in retinal wholemount and single fields of
superficial and deep vascular plexuses in central and peripheral retina of 40-week-old wild-type (WT) retinas. b Representative images of 40-week-old
Pparα-/- retinas. c Decreased total vessel length in superficial and deep vascular plexuses of Pparα-/- retinas. d Decreased number of vascular junctions in
superficial and deep vascular plexuses of Pparα-/- retinas. e Decreased number of meshes in deep vascular plexus of Pparα-/- retinas (adult retinas do not
have meshing in the superficial plexus) (WT, n = 7; Pparα-/-, n = 8 retinas). *P≤ 0.05; **P≤ 0.01; ***P≤ 0.001; ****P≤ 0.0001, Student’s t test
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Figure S5), suggesting that increased use of pyruvate in
Pparα-/- retinas is a compensatory effect, and is not directly
regulated by PPARα.
Impaired mitochondrial function in Pparα-/- retinas
We next characterized retinal mitochondrial activity in
Pparα-/- mice after the onset of retinal degeneration. At
8 weeks of age, basal and maximal retinal OCR were
significantly decreased Pparα-/- retinas (Fig. 5a, b), and
further declined by 12 weeks of age (Fig. 5c, d). This was
partially restored by intravitreal injection of PPARα-
expressing adenovirus (Additional file 6: Figure S6A, B).
Further, siRNA knockdown of PPARα significantly
decreased mitochondrial respiration in cultured R28 rod
Fig. 3 PPARα is essential for utilization of lipid for oxidative phosphorylation. a, b Measurement of (a) retinal oxygen consumption with a Seahorse XFe
analyzer revealed that (b) baseline and maximal retinal oxygen consumption rate (OCR) were significantly increased in wild-type (WT) retinas when long-chain
fatty acid palmitate (Palm) was provided, suggesting that Palm is used as an oxidizable substrate in normal conditions (BSA, n = 12; Palm, n = 11). c, d Retinal
OCR was unaffected by Palm in Pparα-/- retinas, suggesting that retinal use of lipid as an oxidizable substrate is impaired in the absence of PPARα (BSA, n = 9;
Palm, n = 12). e, f Oral administration of PPARα agonist fenofibrate (Feno) for 1 month prior to tissue harvest increased oxygen consumption in isolated rat
retinal mitochondria (mitos) provided with lipid palmitoylcarnitine (PC) as an oxidizable substrate (n = 4). g RNA levels of lipid transporters and fatty acid
oxidation (FAO) enzymes were decreased in Pparα-/- retinas (n = 5/genotype). *P≤ 0.05; **P≤ 0.01; ***P≤ 0.001, unpaired two-tailed Student’s t test
Fig. 4 Compensatory use of glycolytic products for oxidative phosphorylation in the absence of PPARα. a, b In wild-type retinas, OCR was un-
changed by addition of 5 mM pyruvate (Pyr) relative to 0.5 mM Pyr (Veh) control, suggesting that pyruvate was not readily used as an oxidizable
substrate in normal conditions (Veh, n = 11; Pyruvate, n = 10). c, d In Pparα-/- retinas, maximal OCR was increased by pyruvate, suggesting that it
was more readily used as an oxidizable substrate in the absence of PPARα (Veh, n = 11; Pyruvate, n = 9). e Oral administration of PPARα agonist
Fenofibrate (Feno) prior to tissue harvest did not change oxygen consumption in isolated rat retinal mitochondria (Mitos) provided with pyruvate
as an oxidizable substrate (n = 4). *P ≤ 0.05; **P ≤ 0.01; ****P ≤ 0.0001, unpaired two-tailed Student’s t test
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precursor cells (Additional file 6: Figure S6C, D). Oxida-
tion of exogenous NADH, reflective of electron transport
chain activity, was decreased in Pparα-/- retinas relative to
WT (Fig. 5e). Addition of electron transport chain inhibi-
tor rotenone to the assay inhibited NADH oxidation by
more than 10-fold and normalized NADH oxidation in
Pparα-/- retinas relative to WT (Additional file 6: Figure
S6E). Further, in Vldlr-/- retinas, NADH oxidation was
similarly decreased, and restored by systemic treatment
with PPARα agonist fenofibric acid (Fig. 5f), suggesting
that PPARα activation increased retinal energy efficiency
in an AMD-like model. Transmission electron microscopy
(TEM) revealed that photoreceptor mitochondrial morph-
ology in Pparα-/- retinas was consistent with mitochondria
in the orthodox (less active) state relative to WT mito-
chondria, which displayed an active, compressed morph-
ology [18], as supported by our enzymatic analysis
(Fig. 5g). However, we subsequently identified that elec-
tron transport chain and Krebs cycle proteins were un-
changed in Pparα-/- retinas (Additional file 7: Figure S7D,
E), suggesting that the abundance of retinal mitochondria
was unlikely to be changed, and that the observed func-
tional and morphologic changes were likely due to the
established deficits in substrate use.
Proteomic analysis of Pparα-/- retinas
To take an unbiased approach towards identifying meta-
bolic pathways responsible for PPARα regulation of retinal
energy metabolism, we utilized a multiplexed quantitative
proteomics mass spectrometry method to measure retinal
levels of lipid transporters and enzymes essential for FAO,
glycolysis, the citric acid cycle, the electron transport chain,
and antioxidant enzymes [19] in Pparα-/- retinas at 40 weeks
of age. Consistent with earlier RNA analysis, lipid trans-
porters Cpt1a, Fapb3, and Slc25a20 were significantly
decreased in Pparα-/- retinas (Fig. 6b). Glycolytic enzymes
were up-regulated in Pparα-/- retinas (Fig. 6c, Additional
file 7: Figure S7C), which may partially compensate for the
inability to utilize lipid as a fuel source. Most FAO enzymes
were unchanged in Pparα-/- retinas, with the exception
of hydroxy-CoA dehydrogenase (Hadh), which was up-
regulated by PPARα ablation, potentially also as a
compensatory response to decreased overall lipid use
(Additional file 7: Figure S7B). Krebs cycle and electron
transport chain enzymes were unaffected by Pparα ab-
lation (Additional file 7: Figure S7D, E). We observed
that antioxidant enzymes were increased in Pparα-/-
retinas (Fig. 6d, Additional file 7: Figure S7F), suggest-
ing increased reactive oxygen species generation,
Fig. 5 Diminished mitochondrial function in Pparα-/- retinas. a–d Basal and maximal mitochondrial oxygen consumption rate (OCR) were decreased in (a, b)
8-week-old and (c, d) 12-week-old Pparα-/- retinas relative to age-matched wild-type (WT) controls (WT 8 weeks, n = 17; Pparα-/- 8 weeks, n = 20; WT 12 weeks,
n = 21; Pparα-/- 12 weeks, n = 15). e Retinal NADH oxidation was decreased in Pparα-/- retinas relative to age-matched WT controls beginning at 8 weeks of
age (8 weeks WT, n = 10; Pparα-/-, n = 9; 18 weeks, n = 6/genotype; 60 weeks, n = 3/genotype). f Retinal NADH oxidation was decreased in 11-week-old Vldlr-/-
retinas and restored by treatment with PPARα agonist fenofibric acid (Feno) (WT Veh, n = 7; WT Feno-FA, n = 8; Vdllr-/- Veh, n = 7; Vdllr-/- Feno-FA, n = 8). g
Transmission electron microscopy revealed that at 40 weeks of age, photoreceptor mitochondria had an “active” compressed morphology in WT retinas, and
an “inactive” orthodox morphology in Pparα-/- retinas (n = 3/genotype). *P≤ 0.05; **P≤ 0.01; ***P≤ 0.001; ****P≤ 0.0001, unpaired two-tailed Student’s t test
(a–e) or one-way ANOVA with Tukey’s post-hoc comparison (f)
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potentially as a result of decreased mitochondrial effi-
ciency. However, the most significantly upregulated
antioxidant enzymes at 40 weeks of age were un-
changed in 4-week-old Pparα-/- retinas (Additional file
8: Figure S8), suggesting that oxidative stress may not
be responsible for neurodegeneration but is rather a
byproduct of prolonged mitochondrial dysfunction oc-
curring after the onset of neurodegeneration.
Discussion
The retina has high metabolic demands requiring abun-
dant energy substrates, and the ability to utilize lipids as
a fuel source may confer a survival advantage. Lipids
yield more ATP than glucose when used as an oxidizable
substrate [20]. Lipid use may also support continued
ATP production during hypoglycemic fasting periods,
when fatty acids released from adipose tissue can be
used in lieu of glucose for energy production [21].
Interestingly, our recent study identified that in the
retina, the majority of glucose is converted to lactate
through aerobic glycolysis, and that lipids are the
predominant substrate for oxidative phosphorylation [7].
This is supported by our current findings, which
demonstrate that WT retinas readily use lipids for oxida-
tive phosphorylation, and that pyruvate, the primary
glycolytic product used as a substrate for oxidative phos-
phorylation, did not affect mitochondrial respiration. In
contrast, use of lipids for oxidative phosphorylation was
impaired in Pparα-/- retinas, while pyruvate was more
readily used, potentially in a compensatory effect. The
relative roles of glucose versus lipid metabolism in the
retina and preferential, context-dependent use of each
substrate is incompletely understood. In this study, we
underscore the importance of lipids for oxidative metab-
olism, finding that impaired lipid use results in the com-
pensatory use of pyruvate, and ultimately in retinal
energy insufficiency and subsequent neurodegeneration.
This suggests that under stress conditions, retinal neu-
rons are able to use pyruvate for oxidative phosphoryl-
ation, but preferentially use lipids under normal
conditions.
Vldlr-/- mice are deficient in both glucose and lipid
uptake [7], while Pparα-/- mice are deficient in FAO but
not glucose metabolism. Vldlr-/- and Pparα-/- mice had an
equivalent decrease in NADH-linked respiration (Fig. 5e, f),
suggesting similar rates of oxidative phosphorylation, which
Fig. 6 Proteomic analysis of Pparα-/- retinas. a Heatmap representation of lipid transporters, fatty acid oxidation, glycolytic, citric acid cycle, electron transport
chain, and antioxidant enzymes measured by proteomic analysis. Please refer to Additional file 7: Figure S7 for full analysis. b Lipid transporters ATP binding
cassette subfamily d member 3 (Abcd3), carnitine acetyl-transferase (Crat), and carnitine o-octanyltransferase (Crot) were unchanged in 40-week-old Pparα-/-
retinas relative to age-matched wild-type (WT). Carnitine palmitoyltransferase 1a (Cpt1a), fatty acid binding protein (Fabp3), and solute carrier family 25
member 20 (Slc25a20) were decreased in Pparα-/- retinas. c Glycolytic enzymes hexokinase 1 (Hk1), lactate dehydrogenase-brain (Ldhb), phosphofructokinase
muscle (Pfkm), phosphoglycerate mutase 2 (Pgam2), and triosephosphate isomerase 1 (Tpi) were increased in Pparα-/- retinas. d Antioxidant enzymes
glutathione s-transferase alpha-3 (Gsta3), glutathione s-transferase mu 1 (Gstm1), peroxidase-5 and -6 (Prdx5, Prdx6), and thioredoxin reductase 1 (Txnrd1) were
increased in Pparα-/- retinas (WT, n = 6; Pparα-/-, n = 4). *P≤ 0.05, **P≤ 0.01, ***P≤ 0.001, unpaired two-tailed Student’s t test
Pearsall et al. BMC Biology  (2017) 15:113 Page 7 of 14
support the notion that lipids are an important substrate
for oxidative phosphorylation in the retina. However,
Vldlr-/- mice develop both neurodegeneration and patho-
logical neovascularization [7, 15], while Pparα-/- mice
undergo neurodegeneration similar to Vldlr-/- mice (Fig. 1c,
e), but do not develop neovascular lesions [22]. These find-
ings potentially suggest that there may be different roles for
glucose and lipid metabolism in neuronal survival and neo-
vascularization, or that neovascularization results from the
extreme stress of both lipid and glucose deficiency in retinal
neurons. The relative role of glucose versus lipid metabol-
ism in the retina and in retinal disease states is an import-
ant topic of future investigation.
Paradoxically, although Pparα-/- mice do not develop neo-
vascularization or vascular hyperpermeability characteristic
of neovascular eye disease, PPARα activation alleviates neo-
vascularization in Vldlr-/- mice and in ischemic proliferative
retinopathy [7, 17, 22]. Further, Pparα-/- mice have increased
retinal microvascular dysfunction in diabetic conditions [22].
This suggests that although PPARα does not suppress neo-
vascularization in normal conditions, it suppresses it in
pathological conditions, perhaps by improving retinal energy
efficiency. We have also previously demonstrated that
PPARα suppresses pathological Wnt signaling in diabetic
and ischemic retinopathies [22], but found that expression
of Wnt target genes was unchanged in Pparα-/- retinas
(Additional file 9: Figure S9). This further suggests context-
dependent roles for PPARα.
Metabolic dysfunction and resultant bioenergetic aberra-
tions are now recognized as a factor in many aging-related
neurodegenerative conditions. AMD is associated with
mitochondrial dysfunction and energy deficiency [3, 6]. Im-
paired cholesterol metabolism may contribute to formation
of senile plaques and neurofibrillary tangles in Alzheimer’s
disease [4], and metabolic dysregulation has been linked to
Parkinson’s disease [5]. Mitochondrial dysfunction in
neurodegenerative disease may result in impaired ATP
production, and may also increase mitochondrial gener-
ation of reactive oxygen species or initiate mitochon-
drial apoptosis [23]. We demonstrated here that PPARα
activation improves mitochondrial efficiency and
utilization of lipids as an energy source, which may
therefore alleviate aging-related mitochondrial dysfunc-
tion. PPARα agonists are in common clinical use and
are well-tolerated, and may therefore be an effective
therapeutic approach for age-related neurodegeneration
occurring secondary to metabolic dysregulation.
Conclusions
Here we revealed a new role for endogenous PPARα in
retinal neuronal energy metabolism, and demonstrated
that utilization of lipids as a fuel source is critical to the
survival of retinal neurons. These findings have three
major implications: (i)PPARα is essential for retinal
neuronal survival and lipid metabolism in physiological
conditions; (ii) PPARα activation increases retinal energy
efficiency and utilization of lipids as an energy substrate
(iii) PPARα may be a new therapeutic target for AMD and
other neurodegenerative conditions of metabolic origin.
This work advances basic understanding of retinal energy
metabolism and has significant translational potential.
Methods
Experimental animals
Mice: C57Bl/6 J, Pparα-/-, and Vldlr-/- mice were originally
purchased from Jackson Laboratories (Bar Harbor, ME,
USA). Both Pparα-/- and Vldlr-/- mice were global dele-
tions. Experimental animals were bred in-house. For all
experiments, animals were maintained on a 12-hour light-
dark cycle on a standard laboratory rodent diet (Purina
5053). Four-week-old WT and Pparα-/- mice were injected
with either GFP- or PPARα-expressing adenovirus (1 μL
of 2.52 × 109 vector particles/mL) 4 weeks prior to sacri-
fice. Vldlr-/- mice and WT controls were injected intraper-
itoneally with 20 mg/kg fenofibric acid (AK Scientific,
Union City, CA, USA) daily for 2 weeks prior to sacrifice.
For terminal studies, animals were euthanized with carbon
dioxide asphyxiation, 200 mg/kg pentobarbital (Virbac, Ft.
Worth, TX, USA) or 300/60 mg/kg ketamine/xylazine
(Virbac) as specified for each assay.
Rats: Sprague–Dawley rats were purchased from
Charles River Laboratories (Wilmington, MA, USA) at
8 weeks of age and maintained on a 12-hour light-dark
cycle. Rats were fed with control or fenofibrate-
containing chow (Purina 5053) for 1 month prior to the
experimental endpoint. Fenofibrate was purchased from
Sigma-Aldrich (St. Louis, MO, USA) and blended
homogenously with chow for a final dose of 20 mg/kg
fenofibrate per day (Test Diet, Ft. Worth, TX, USA).
Rats were euthanized with 200 mg/kg pentobarbital.
Electroretinograms (ERGs)
ERG recordings were conducted in WT and Pparα-/-
mice at 7, 9, 11, 26, and 52 weeks of age as described
previously [15]. Briefly, mice were dark-adapted at least
12 hours prior to the procedure, and were then anesthe-
tized with an 85/12 mg/mL ketamine/xylazine mixture.
Pupils were dilated with Atropine (Alcon Laboratories,
Ft. Worth, TX, USA) just prior to the procedure. ERG
responses were recorded with a platinum needle
electrode placed on the corneal surface, a reference elec-
trode placed at the nasal formix, and a ground electrode
on the foot. Fourteen responses to a light stimulus of 10
mSec with flash intervals of 20 sec were recorded. For
quantitative analyses, the B-wave amplitude was
measured between A- and B-wave peaks. N is expressed
as number of animals per genotype, per time point.
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Optical coherence tomography (OCT)
OCT was used to measure total retinal thickness in WT
and Pparα-/- mice at 13, 28, and 60 weeks of age. Mice
were anesthetized and pupils dilated as described above.
OCT images were taken using an Envisu R2000 imaging
system (Bioptegen, Durham, NC, USA). Retinal scans were
collected from both eyes of each mouse; 3–4 en face scans
were collected from each retina, with each en face scan
consisting of 100 B-scans and 1000 A-scans per B-scan.
Total retinal thickness was measured using the manual
digital caliper feature in the Envisu software, and was mea-
sured as the distance from the inner retinal nerve fiber
layer to the outer retinal pigment epithelial layer. Measure-
ments were made at 0°, 90°, 180°, and 270° on each retina
at a radius of 500 μm. The 0° measurement on “OD” im-
ages and the 180° measurement on “OS” images were used
for the temporal quadrant, and the opposite measurements
were used for the nasal quadrant. N is expressed as num-
ber of animals per genotype, per time point.
Cell death ELISA
A DNA fragmentation ELISA (Cell Death Detection ELISA;
Roche Applied Science, Indianapolis, IN, USA) was used to
quantify total retinal apoptosis in WT and Pparα-/- mice at
4, 8, 18 and 40 weeks of age and in 11-week-old WT and
Vldlr-/- mice ± fenofibric acid as described previously [16,
24]. Mice were euthanized with carbon dioxide asphyxiation
and retinas quickly excised. Retinas were homogenized in
lysis buffer, incubated 30 minutes at room temperature, and
spun down to generate a cytoplasmic fraction. The cytoplas-
mic fraction was then subjected to ELISA analysis as per
the manufacturer’s protocol, and relative fragmentation was
expressed as OD (405/490 nm) normalized by total protein
content as measured by RC/DC assay (Biorad, Hercules,
CA, USA) OD (750 nm). N is expressed as number of ret-
inas per genotype, per time point.
Western blotting
Western blotting was used to measure retinal GFAP levels
in WT and Pparα-/- mice at 8, 15, and 40 weeks of age as
described previously [25]. Mice were euthanized with car-
bon dioxide asphyxiation and retinas were snap-frozen in
liquid nitrogen. One retina per animal was homogenized
in Holt’s lysis buffer, and 10 μg of protein were resolved by
SDS-PAGE and transferred to a nitrocellulose membrane.
Membranes were probed with GFAP antibody (Sigma; Cat
# G3893; RRID AB_477010) and subsequently reprobed
with HRP-conjugated β-actin (Santa Cruz Biotechnology,
Santa Cruz, CA, USA; Cat # sc-47778 HRP; RRID
AB_2714189). Band density was quantified using Alpha
Imager software (San Jose, CA, USA). N is expressed as
number of retinas per genotype, per time point.
Isolectin staining, flatmount, and vascular density
quantification
To image retinal vasculature in WT and Pparα-/- mice,
isolectin staining was used as described previously [26].
Mice were euthanized with carbon dioxide asphyxiation
and whole eyes were fixed in 4% paraformaldehyde for
1 hour and washed with PBS for 10 minutes, three
times. Retinas were then dissected and penetrated with
70% ice-cold ethanol at room temperature for 30 mi-
nutes, and subsequently penetrated in 1% TPBS (Triton
X-100) for 1 hour at room temperature. Retinas were
then stained with fluorescent Griffonia simplicifolia
isolectin B4 (Invitrogen, Carlsbad, CA, USA) overnight.
The stained retinas were washed in three times in PBS
for 30 minutes, and subsequently flat-mounted in
glycerol media for fluorescent imaging.
To quantify vascular density, single fields of the superfi-
cial and deep vascular plexuses in the central and peripheral
retina (four fields per retina, one field per quadrant) were
imaged at 200× magnification (dimensions: 1388 × 1040).
Prior to analysis, the background of each image was se-
lected and cropped manually in Image J using the freehand
tool. The background color was set as black. The image
was converted to 8 bit before using “Analyze HUVEC Fluo”
in the Angiogenesis Analyzer tool for ImageJ. (http://ima-
ge.bio.methods.free.fr/ImageJ/?Angiogenesis-Analyzer-for-
ImageJ). Total vessel length per field, number of junctions
per field, and number of meshes per field were used as
parameters for the evaluation of retinal vascular network. N
is expressed as the number of retinas quantified per
genotype, per time point.
Fatty acid oxidative capacity
To measure fatty acid oxidative capacity of WT and
Pparα-/- retinas, oxygen consumption rates after addition
of fatty acid BSA-conjugated palmitate or BSA vehicle
were measured using a Seahorse XFe96 Flux Analyzer®
as described previously [7], with minor modifications.
Mice were euthanized with ketamine/xylazine, whole
retinas were isolated and 1 mm punch biopsies were
loaded into a 96-well spheroid plate. Retinal punches
were incubated in assay media consisting of DMEM
5030 supplemented with 20 mM glucose, 5 mM
pyruvate, 2 mM glutamine, 10 mM HEPES, and 0.5 mM
carnitine (Sigma), and 30 μL BSA-conjugated palmitate
or BSA vehicle control (Seahorse/Agilent, Santa Clara,
CA) were added to a final concentration of 168 μM just
prior to commencing the assay. The Seahorse XF Mito
Stress Test Kit® was used to assess mitochondrial
respiration as described in the manufacturer’s protocol
with minor modifications. Oligomycin was injected in
Port A to a final concentration of 3 μM, trifluoro-
methoxyphenylhydrazone (FCCP) was injected in Ports
B and C to a final concentration of 1.5 μM, and
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rotenone/antimycin A (RAA) was injected in Port D to a
final concentration of 4 μM rotenone/4 μM antimycin
A. Basal respiration was calculated by subtracting non-
mitochondrial respiration (rate after injection of RAA)
from the basal rate. Maximal respiration was calculated
by subtracting non-mitochondrial respiration from the
rate after injection of FCCP. Fold change in basal and
maximal respiratory rates was calculated by dividing
basal and maximal rates of palmitate-treated punches by
that of BSA-treated punches. To determine if increased
OCR in palmitate-treated retinas was due to fatty acid
oxidation, control punches were treated with 40 μM
Cpt1a inhibitor etomoxir (Sigma) or vehicle control for
1 hour prior to commencing the assay. N is expressed as
the number of retinal punches per treatment group.
Pyruvate oxidative capacity
To determine whether pyruvate was used as an oxidizable
substrate in WT and Pparα-/- retinas, the retinal OCR was
measured after addition of pyruvate using a Seahorse
XFe96 Flux Analyzer®. Mice were euthanized with
ketamine/xylazine, whole retinas were isolated and 1 mm
punch biopsies were loaded into a 96-well spheroid plate.
Retinal punches were incubated in assay media consisting
of DMEM 5030 supplemented with 5 mM glucose, 0.5 mM
pyruvate, 2 mM glutamine, and 10 mM HEPES. Assay
media (vehicle) control or high-pyruvate-containing assay
media were injected into port A to a final concentration of
5 mM pyruvate in pyruvate-injected punches, and 0.5 mM
pyruvate in vehicle-injected punches. Oligomycin was
injected into port B to a final concentration of 1 μM, FCCP
was injected into port C to a final concentration of 2 μM,
and RAA was injected in Port D to a final concentra-
tion of 2 μM rotenone/2 μM antimycin A. Maximal
respiration was calculated by subtracting non-
mitochondrial respiration from the rate after injection
of FCCP. Fold change in maximal respiratory rate was
calculated by dividing the maximal rate of pyruvate-
injected punches by that of vehicle-injected punches
for both genotypes. N is expressed as the number of
retinal punches per treatment group.
Isolation of retinal mitochondria
Retinal mitochondria were isolated as described previously
[27] with minor modifications from rats fed fenofibrate
(20 mg/kg) or vehicle 1 month prior to sacrifice. Rats were
euthanized with pentobarbital. Retinas were rapidly
excised and homogenized in 5-mL ice-cold buffer A
(210 mM mannitol, 70 mM sucrose, 1.0 mM EDTA,
5.0 mM MOPS, pH 7.4) with four retinas per preparation.
Retinas were then subjected to five passes with a motor-
driven Potter–Elvehjem tissue grinder and spun at 500 g
for 5 min at 4 °C. The supernatant was subsequently
collected and passed through a cheesecloth, then spun
again at 500 g for 10 min. The resultant mitochondrial
pellet was resuspended in 40 μL of buffer A and protein
concentration determined by BCA assay (Pierce, Green
Island, NY, USA) according to the manufacturer’s protocol.
Mitochondrial respiration in isolated mitochondria
Mitochondrial respiration was measured in retinal mito-
chondria from rats fed fenofibrate or vehicle as de-
scribed previously [27]. Mitochondria were diluted to
0.25 mg/mL in buffer B (210 mM mannitol, 70 mM su-
crose, 5.0 mM KH2PO4, and 10 mM MOPS, pH 7.4)
containing either 0.1 mM pyruvate/1.0 mM malate or
30 μM palmitoylcarnitine/0.1 mM malate/0.5 mg/mL
BSA. Respiration was measured at 20 °C using a fiber
optic oxygen measurement system that employs the
fluorescence lifetime technique (Instech, Plymouth
Meeting, PA, USA). State 3 respiration was initiated by
addition of 0.5 mM ADP (Sigma). N is expressed as the
number of mitochondrial preparations per treatment
group, with four retinas per preparation.
Mitochondrial respiration in intact retinas
To determine whether mitochondrial respiration was
changed in WT and Pparα-/- retinas after onset of neurode-
generation, retinal oxygen consumption rate (OCR) was
measured in 8- and 12-week-old retinas using a Seahorse
XFe96 Flux Analyzer®. Mice were euthanized with
ketamine/xylazine, whole retinas were isolated and 1 mm
punch biopsies were loaded into a 96-well spheroid plate.
Retinal punches were incubated in assay media consisting of
DMEM 5030 supplemented with 12 mM glucose, 5 mM
pyruvate, 2 mM glutamine and 10 mM HEPES. Oligomycin
was injected into port A to a final concentration of 2 μM,
FCCP was injected into port B and C to a final concentra-
tion of 1 μM, and Rotenone/Antimycin A (RAA) was
injected in Port D to a final concentration of 2 μM
rotenone/2 μM Antimycin A. Basal respiration was cal-
culated by subtracting non-mitochondrial respiration
from the basal rate prior to injection of Oligomycin.
Maximal respiration was calculated by subtracting non-
mitochondrial respiration from the rate after injection
of FCCP. N is expressed as the number of retinal
punches per treatment group.
Adenovirus preparation
PPARα-expressing adenovirus was generated previously
[17]. Ad-GFP prepared previously was used as a control.
Preparation, amplification, and titration of the recom-
binant adenoviruses was performed as described previ-
ously [28, 29].
In vitro PPARα knockdown and extracellular flux analysis
R28 rod precursor cells were a kind gift of Dr. Gail
Seigel [30]. Cells were cultured in Dulbecco’s modified
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Eagle’s medium (DMEM) containing 1 mM D-glucose,
10% heat-inactivated fetal bovine serum (FBS; Cellgro,
Manassas, VA, USA) and 1% antibiotic-antimycotic
solution (Cellgro).
Transfection
Smartpool siRNA (Dharmacon, Lafayette, CO, USA)
targeting rat PPARα or scrambled control was delivered into
R28 cells by Hiperfect (Qiagen) by reverse transfection
following the manufacturer’s protocol. Briefly, 5000 or
120000 R28 cells/well were seeded in an Agilent Seahorse
XF96 cell culture microplate or a 12-well plate, respectively.
At the same time, cells received 50nM siRNA diluent mixed
with Hiperfect. Forty-eight hours after transfection,
knockdown efficiency was detected by real-time PCR and
oxygen consumption rate was measured using a Seahorse
XFe96 Flux Analyzer®.
Seahorse extracellular flux analysis
Forty-eight hours after transfection, oxygen consump-
tion rates were measured using a Seahorse XFe96 Flux
Analyzer® following the manufacturer’s protocol. Oligo-
mycin was injected into port A to a final concentration
of 2 μM, FCCP was injected into port B to a final con-
centration of 6 μM, and Rotenone/Antimycin A (RAA)
was injected in Port C to a final concentration of 4 μM
rotenone/4 μM Antimycin A. Maximal respiration was
calculated by subtracting non-mitochondrial respiration
from the rate after injection of FCCP. After measure-
ment of oxygen consumption rates, cells were lysed in
30 μl 1X SDS loading buffer. The lysate was resolved by
SDS-PAGE and transferred to a nitrocellulose mem-
brane. Membranes were probed with HRP-conjugated
anti-β-Actin (Santa Cruz Biotechnology). Band density
was quantified using Image J. OCR data was normalized
by the density of β-Actin. N is expressed as the number
of wells per treatment group.
NADH oxidation assay
To quantify mitochondrial NADH-linked respiration,
the consumption of exogenously added NADH was mea-
sured spectrophotometrically in WT vs. Pparα-/- retinas
and in WT and Vldlr-/- retinas ± fenofibric acid as de-
scribed previously [31] with minor modifications. Ani-
mals were euthanized with pentobarbital, and retinas
rapidly excised and snap-frozen in liquid nitrogen. Ret-
inas were homogenized in 250 μL 25 mM MOPS/1 mM
EDTA pH 7.4 and sonicated. Prior to the reaction, ret-
inal homogenates were diluted 1:20 in assay buffer
(25 mM MOPS/10 mM KCl, pH 7.4). Exogenous NADH
(100 μM; Sigma) was added and its oxidation rate moni-
tored spectrophotometrically at 340 nm. Protein concen-
tration of retinal homogenates was measured using a
BCA assay as described above. Data are expressed as
ratio of nmol NADH consumed per minute per mg of
total retinal protein in control versus experimental
group. To verify that observed changes in NADH con-
sumption were due to NADH-linked respiration, com-
plex I inhibitor rotenone (3.5 μM; Sigma) was added to
the reaction described above. All assays were performed
at room temperature. N is expressed as the number of
retinas per genotype, per time point.
Reverse transcription and quantitative real-time PCR
Lipid transporter and FAO enzyme RNA levels were
measured in WT vs. Pparα-/- retinas using quantitative
real-time PCR (qRT-PCR) as described previously [7],
with minor modifications. Briefly, mice were euthanized
with carbon dioxide asphyxiation and retinal RNA was
isolated using a Qiazol (Qiagen, Valencia, CA, USA)
extraction, purified using a PureLink® RNA Mini Kit
(Qiagen) and treated with DNase I (Qiagen) to remove
contaminating genomic DNA. DNase-treated RNA was
then converted into cDNA using iScript® reverse tran-
scriptase (BioRad, Hercules, CA, USA). PCR primers for
target genes and housekeeping gene β-actin were
designed using NCBI Primer Blast and OligoCalc software.
Primer sequences are shown in Table 1. Quantitative ana-
lysis of gene expression was conducted using a BioRad
CFX96® system with a SYBR Green Master Mix kit (Bio-
Tools, Jupiter, FL, USA) and target gene expression was cal-
culated relative to β-actin using the ΔcT method. For in
vivo studies, N is expressed as the number of retinas per
genotype. For in vitro studies, N is expressed as the number
of wells per group.
Transmission electron microscopy (TEM)
TEM was utilized to compare mitochondrial morphology
in WT versus Pparα-/- retinas as described previously [32].
Mice were euthanized with carbon dioxide asphyxiation
and perfused with 4% paraformaldehyde for 30 minutes.
Eyes were removed and fixed overnight, and retinas subse-
quently excised. Tissue sections were generated using a
microtome (Reichert-Jung Ultracut E Microtome, American
Instrument, Haverhill, MA, USA) with a diamond knife.
Sections (600–800 Å) were collected on copper 75/300 mesh
grids for conventional TEM analysis and stained with 2%
uranyl acetate and Reynolds’ lead citrate to examine the
morphology of photoreceptor mitochondria. Sections were
viewed with a transmission electron microscope (JEOL
100CX; JEOL USA Inc., Peabody, MA, USA) at an acceler-
ation voltage of 50 keV. Digital images were collected and
stored on a computer for subsequent viewing and analysis.
Three retinas from three separate animals were used for
each genotype, and over 100 retinal mitochondria were
imaged for each animal.
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Mass spectrometry
Mass spectrometry was utilized for targeted quantitative
proteomic analysis of metabolic pathways in WT versus
Pparα-/- retinas as previously performed albeit with
minor modifications [19].
Sample preparation
Mice were euthanized with carbon dioxide asphyxiation
and PBS-perfused. Retinas were dissected and snap-
frozen in liquid nitrogen. Both retinas from each animal
were homogenized in 200 μL Holt’s lysis buffer and
sonicated, then spun at 500 g for 5 min at 4 °C, and the
supernatant was collected. Protein was quantified using
a BioRad detergent compatible kit (Hercules, CA)
according to the manufacturer’s protocol. The volume
equivalent to 60 μg protein was taken for analysis, and
8 pmol of bovine serum albumin were added as a non-
endogenous internal standard. Samples were mixed,
heated and cooled to room temperature. Acetone
(1 mL) was added and proteins were precipitated over-
night at –20 °C. The resultant pellet was reconstituted
in 60 μL of sample loading buffer and a 20 μL aliquot
was resolved by short-run gel electrophoresis (1.5 cm
into gel), gel-fixed, and stained. Each lane was cut as a
single sample, washed, reduced with DTT, alkylated
with idoacetamide, and digested overnight with trypsin.
The peptides from the digestion were extracted, evapo-
rated to dryness, and reconstituted in 150 μL 1% acetic
acid for analysis.
LC-tandem mass spectrometry analysis
An Eskigent nanoflow system (Sciex, Framingham, MA,
USA) was used for liquid chromatography (LC) and
ThermoScientific TSQ Vantage triple quadrupole was used
for mass spectrometry (Thermo Scientific, San Jose, CA,
USA). A 75 μM×11 cm column packed with Phenometrix
Jupiter C18 was used. Sample aliquots (6 μL) were injected
for each analysis. Peptides were eluted with a linear gradi-
ent of acetonitrile in water with 0.1% formic acid. For data
analysis, the open-source program Skyline (developed by
Dr. Michael MacCoss, University of Washington) was used.
Total protein responses were calculated as the geometric
mean of the abundance of peptides measured for each
protein, and normalized to bovine serum albumin (BSA)
total protein response. The final abundance of each protein
was calculated as pmol/100 μg total protein based on the
ratio in relation to BSA and the amount of BSA added, and
data were expressed as the amount of protein in experi-
mental groups relative to control.
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Statistics
Results are expressed as mean ± SEM. A two-tailed,
unpaired Student’s t test was used for two-group com-
parisons, and a one-way ANOVA with Tukey’s posthoc
comparison was used for studies with more than two
experimental groups. P values of less than 0.05 were
considered statistically significant.
Additional files
Additional file 1: Figure S1. (A) Multiple intensity electroretinograms
confirmed that retinal function was suppressed in 36-week-old Pparα-/- mice
relative to wild-type (WT) when multiple flicker durations were utilized (n = 5
mice/genotype). (B) Representative scotopic (rod) electroretinogram traces
from a 36-week-old WT mouse at multiple flicker durations. (C) Representative
scotopic (rod) electroretinogram traces from a 36-week-old Pparα-/- mouse at
multiple flicker durations. (D) Representative photopic electroretinogram trace
from a 36-week-old WT mouse. (E) Representative photopic electroretinogram
trace from a 36-week-old Pparα-/- mouse. (F) Retinal cell death ELISA
demonstrated that intravitreal injection of PPARα-expressing adenovirus
alleviated retinal apoptosis in 8-week-old Pparα-/- mice (WT ad-GFP n = 5;
Pparα-/- ad-GFP n = 6; Pparα-/- ad-PPARα n = 7). Data are expressed as mean ±
SEM. *P≤ 0.05; ***P≤ 0.001; ****P≤ 0.0001, unpaired Student’s t test (A) or
one-way ANOVA with Tukey’s post-hoc comparison (F). Figure S1 pertains to
Fig. 1 of the main text. (TIF 21187 kb)
Additional file 2: Figure S2. (A–C) Full gels for immunoblots shown in
Fig. 1d. Gels are loaded alternating wild-type (WT) and Pparα-/- retinal
lysates of specified ages. Rectangles denote representative bands in-
cluded in figure 1D. (D) At 15 and 40 weeks of age, a 45 kDa isoform of
GFAP was present, and was increased in Pparα-/- retinas relative to age-
matched WT controls (15 weeks n = 5 retinas/genotype; 40 weeks n = 6 ret-
inas/genotype). **P≤ 0.01, unpaired two-tailed Student’s t test. Figure S2 per-
tains to Fig. 1 of the main text. (TIF 24547 kb)
Additional file 3: Figure S3. (A) Representative images of isolectin-labeled
microvessels in retinal wholemount and single fields of superficial and deep
vascular plexuses in central and peripheral retina of 8-week-old wild-type (WT)
retinas. (B) Representative images of 8-week-old Pparα-/- retinas. (C) Modestly
decreased total vessel length in the central retinal region of the deep vascular
plexus in Pparα-/- retinas. (D) Modestly decreased number of vascular junctions
in the central retinal region of the deep vascular plexus in Pparα-/- retinas. (E)
Decreased number of meshes in central region of deep vascular plexus of
Pparα-/- retinas (adult retinas do not have meshing in the superficial plexus) (n
= 10 retinas/genotype). *P≤ 0.05; **P≤ 0.01, unpaired two-tailed Student’s t
test. Figure S3 pertains to Fig. 2 of the main text. (TIF 31492 kb)
Additional file 4: Figure S4. (A, B) Palmitate (Palm)-induced increases in
oxygen consumption rate (OCR) in wild-type (WT) retinas were reversed by
Cpt1a inhibitor etomoxir (Eto), suggesting that increased OCR with palm is
due to increased fatty acid oxidation (BSA n = 12; Palm n = 10; Palm+ Eto
n = 12). (C, D) Palm and Eto do not change OCR in Pparα-/- retinas (BSA n = 9;
Palm n = 12; Palm+ Eto n = 9). (E) RNA levels of fatty acid oxidation enzymes
are unchanged in 4-week-old Pparα-/- retinas relative to age-matched WT
(n= 5). Please refer to Additional file 10: Table S1 for full names of genes
presented in Additional file 3: Figure S3C. *P ≤ 0.05, unpaired two-tailed
Student’s t test. Additional file 3: Figure S3 pertains to Fig. 3 of the main
text. (TIF 12372 kb)
Additional file 5: Figure S5. Representative oxygen consumption trace
for pyruvate substrate use experiment in isolated retinal mitochondria from
fenofibrate-treated rats shown in Fig. 4e of main text, demonstrating no
change in oxygen consumption with fenofibrate treatment when pyruvate
is provided as an oxidizable substrate (n = 4). Figure S5 pertains to Fig. 4 of
the main text. (TIF 6362 kb)
Additional file 6: Figure S6. (A-B) Seahorse extracellular flux analysis
demonstrated that intravitreal injection of PPARα-expressing adenovirus
restored deficient retinal mitochondrial respiration in 8-week-old Pparα-/-
mice (wild-type (WT) ad-GFP n = 19; Pparα-/- ad-GFP n = 25; Pparα-/- ad-PPARα
n= 19). (C) Seahorse extracellular flux analysis demonstrated that siRNA
knockdown of PPARα in R28 rod precursor cells decreased mitochondrial res-
piration (siScr n = 7; siPPARα n= 6). (D) siRNA knockdown of PPARα reduces
mRNA levels by ~50% in R28 cells (n = 4). (E) NADH oxidation assay revealed
that NADH oxidation was decreased in 8-week-old Pparα-/- retinas
relative to age-matched WT, which was significantly abrogated by
complex I inhibitor rotenone. NADH oxidation was unchanged in
Pparα-/- retinas relative to WT in rotenone-inhibited reactions (WT n = 10;
Pparα-/- n = 9). B: *P≤ 0.05 vs. WT-GFP, #P≤ 0.05 vs. Pparα-/- + GFP, one-way
ANOVA with Tukey’s post-hoc comparison. C–E: **P≤ 0.01; ***P≤ 0.001;
****P≤ 0.0001, unpaired two-tailed Student’s t test. Figure S6 pertains to
Fig. 5 of the main text. (TIF 12715 kb)
Additional file 7: Figure S7. (A) Heatmap representation and gene
symbols of proteins measured by proteomic analysis. Please refer to
Additional file 10: Table S1 for full gene names. (B) Fatty acid oxidation
enzymes are unchanged in Pparα-/- retinas relative to wild-type with
exception of Hadha, which is upregulated. (C) Glycolytic enzymes Hk1,
Ldhb, Pfkm, Pgam2, and Tpi are upregulated in Pparα-/- retinas. (D) Krebs
cycle enzymes are unchanged in Pparα-/- retinas. (E) Electron transport
chain enzymes are unchanged in Pparα-/- retinas. (F) Antioxidant enzymes
Gsta3, Gsm1, Msra, Prdx5, Prdx6, Sod1, and Txnrd1 are upregulated in
Pparα-/- retinas. WT n = 6, Pparα-/- n = 4. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001,
two-tailed unpaired Student’s t test. Figure S7 pertains to Fig. 6 of the
main text. (TIF 28635 kb)
Additional file 8: Figure S8. At 4 weeks of age, antioxidant enzymes
upregulated at 40 weeks (S7F) are unchanged in Pparα-/- retinas relative to
age-matched wild-type. For full gene names refer to Additional file 10:
Table S1. n = 5 retinas/genotype. Statistically insignificant as indicated by
P≥ 0.05, two-tailed unpaired Student’s t test. Figure S8 pertains to Fig. 6 of
the main text. (TIF 7076 kb)
Additional file 9: Figure S9. Retinal expression of Wnt target genes
was unchanged in Pparα-/- retinas relative to wild-type at 8 weeks of age.
N = 5 retinas/genotype. Statistically insignificant as indicated by P ≥ 0.05,
two-tailed unpaired Student’s t test. (TIF 6448 kb)
Additional file 10: Table S1. Genes presented in Figures S4, S7 and S8.
(DOCX 124 kb)
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